Enhancing Cognitive and Neurobehavioral Functions After Repetitive Traumatic Brain Injuries (rTBI) in Retired NFL Players and Military Veterans.
| Status: | Recruiting |
|---|---|
| Conditions: | Cognitive Studies, Neurology |
| Therapuetic Areas: | Neurology, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 25 - 55 |
| Updated: | 4/21/2016 |
| Start Date: | February 2016 |
| End Date: | December 2017 |
| Contact: | Robert W Van Boven, M.D., D.D.S. |
| Email: | brainbodyhealthfoundation@gmail.com |
| Phone: | 512-981-5801 |
The purpose of this study is to compare different combinations of cognitive training in
retired professional football players and military veterans with a history of repeated
concussions and persistent symptoms of impaired memory, concentration, attention, focus, or
thinking.
retired professional football players and military veterans with a history of repeated
concussions and persistent symptoms of impaired memory, concentration, attention, focus, or
thinking.
Inclusion Criteria:
- History of >1 Mild TBI: post traumatic amnesia/confusion ≤ 24 hour immediately after
injury; or loss of consciousness <30 min confirmed by the Ohio State University TBI
Identification Method-Short Form (OSU TBI-ID-SF).
- Age 25-55 years
- Minimum of 4 months post-injury
- Adequate visual, auditory, sensory-motor function for training program.
- Fluent in English
- Persistent cognitive dysfunction confirmed by Ruff Neurobehavioral Inventory score of
greater than 70 on any of the four cognitive scales (Attention, Memory, Language,
Executive).
Exclusion Criteria:
- History of hypoxic event
- Pre-existing significant neurological (e.g. MS) or psychiatric (e.g. schizophrenia,
bi-polar) disorders.
- Current illicit drug use or alcohol abuse
- Unwilling or unable (e.g. language barrier) to participate
- Hospitalization during study
- Current Litigation
- Positive on malingering test
- Use of medications to enhance cognitive function (e.g. Ritalin)
- Initial Glasgow Coma Score < 13 or penetrating head injury
- Subjects must not show suicidal ideation as measured by the Columbia-Suicide Severity
Rating Scale. Subjects with a score of 4 or 5 (as recommended by the FDA for
treatment trials) will be excluded and referred for appropriate treatment.
- Subjects should not be enrolled in a concurrent TBI clinical trial.
We found this trial at
1
site
Click here to add this to my saved trials
